Last reviewed · How we verify
NCT03519321
Minimal Invasive Deformity Correction (MID-C) System for Early Onset Scoliosis
NA trial testing MID-C in Scoliosis in 60 participants. Status unknown.
20 June 2023
Quick facts
| Lead sponsor | Apifix |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 11 April 2018 |
| Primary completion | 20 June 2023 |
| Estimated completion | 20 July 2023 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- MID-C
Conditions studied
- Scoliosis — all drugs for Scoliosis →
- Scoliosis Idiopathic — all drugs for Scoliosis Idiopathic →
- Scoliosis;Congenital — all drugs for Scoliosis;Congenital →
Sponsor
Apifix
Who can join
Adults 6 to 11, any sex, with Scoliosis or Scoliosis Idiopathic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early Onset Scoliosis (EOS) is defined as scoliosis with onset under the age of ten years, regardless of etiology. It is a complex three-dimensional deformity of the spine which can cause significant physical and psychological problems. Currently there are two basic treatment options available for EOS: non-surgical and surgical. ApiFix Ltd. has developed a novel growing rod system for surgical treatment of EOS, the MID-C system. It is indicated for patients with a scoliosis of 35 to 75 degrees Cobb angle
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03519321
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MID-C
Trials testing the same drug.
- NCT04003233 — Limited-efficacy Testing of Spring Distraction System (SDS) and Unilateral One-way Rod (MID-C) for Early Onset Scoliosis · NA · withdrawn
Other recruiting trials for Scoliosis
Currently open trials in the same condition.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07059663 — Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients · NA · recruiting
- NCT06540885 — A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery · Phase 4 · recruiting
- NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
- NCT06451562 — Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery · NA · recruiting
Other Apifix trials
Trials by the same sponsor.
- NCT04684927 — PMS Evaluation of Safety and Efficacy of the MID-C System 5 Years Post-implantation in AIS · NA · withdrawn
- NCT04296903 — Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post- · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03519321 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Apifix
- Last refreshed: 22 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03519321.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing